IQVIA Digital Site Suite

41. Say It With Technology: How Alnylam Fosters A Connected Relationship With Sites 3/12/2021

    Alnylam Pharmaceuticals is developing an entirely new class of medicines and delivered the world’s first and only approved RNAi therapeutics in 2018 and 2019. Learn how Alnylam earned its reputation among investigators as a sponsor of choice by standardizing studies on a collaborative portal more than 6 years ago and leveraging technology to deliver results.

42. Navigating Complexities In Global Payment Operations: Best Practices For Sponsors 12/7/2020

    Deploying a successful global program for paying clinical research sites is an achievable and worthwhile goal but requires an understanding of the differences in frameworks and motivations. Learn what is needed to pays site globally in a reliable, timely, and equitable manner.

43. Global Pharma Company Dramatically Improves Collaboration, Communication, And Compliance In Trials 10/9/2020

    A Top 5 global pharmaceutical company wanted to help sites do everyday tasks more efficiently, making it easier for site staff to adhere to the protocol and deliver high-quality data. After evaluations and pilots, the company deployed an Investigator Site Portal in a 4-phase approach that delivered benefits each step of the way.

44. How Technology And Relationships Can Improve Feasibility 8/31/2020

    Conducting feasibility is an essential and necessary step to starting up a clinical trial. The good news is that the whole approach has the ability to change for the better by initiating and adopting some enhancements.

45. Best Practices For Site Communications During COVID-19 6/8/2020

    With so much new and updated information being shared on nearly a daily basis, it’s important to consider the most effective methods of organization and distribution. Here are some best practices we’ve compiled from working with sponsors and sites of all sizes and specialties during the COVID-19 pandemic.  

46. IQVIA Learning Management System 5/20/2020

    IQVIA’s Learning Management System (LMS) provides sites and study teams with a single, efficient source for education and learning, knowledge assessments, reporting and more.

47. IQVIA Safety Notifications 5/20/2020

    Now featuring cross-trial functionality, IQVIA Safety Notifications gives sponsors and contract research organizations (CROs) a centralized, simple solution for disseminating, managing, and tracking SUSARs and other safety notifications.

48. IQVIA Investigator Site Portal 5/20/2020

    IQVIA Technologies’ Investigator Site Portal (formerly DrugDev) offers sponsors, CROs, and sites the ability to manage trials easily and efficiently, from beginning to end, by enabling users to communicate effortlessly with sites, design and execute goals, and provide reporting, trial metrics, and much more.

49. How To Boost Support To Sites With Digital Clinical Technologies During The COVID-19 Crisis And Beyond 5/9/2020

    Digital solutions previously viewed as “nice to have” for clinical trial optimization are now proving to be vital to support sites. Here are five areas where we have seen sponsors take advantage of digital clinical technologies to boost support to sites and enable innovative drug development to continue - not only during the COVID-19 crisis but well into the future.

50. Staying Connected In Crisis: Strong Site Communication Channels Stand Up To Pressure 4/14/2020

    The COVID-19 pandemic is presenting unprecedented challenges to the clinical trial industry. Sites are in an unprecedented state of flux, and the pressure to understand the situation, protect patients and providers, and determine how to ensure continuity is on. Now more than ever, strong communication channels between sponsors and sites are critical.